[Neonatal nosocomial infections]

M M Mussi-Pinhata1, S D Nascimento

  • 1Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Jornal De Pediatria
|December 17, 2003
PubMed

Insights

Neonatal nosocomial infections are a significant concern, affecting vulnerable newborns, especially preterm infants. Effective control requires comprehensive strategies targeting the hospital environment, staff, and neonates, alongside ongoing surveillance.

Area of Science:

  • Neonatalogy
  • Infectious Diseases
  • Public Health

Background:

  • Neonates, particularly preterm infants in intensive care, possess unique vulnerabilities predisposing them to healthcare-associated infections.
  • Invasive procedures and broad-spectrum antibiotic use in neonatal intensive care units contribute to high prevalence rates of neonatal nosocomial infections.

Purpose of the Study:

  • To comprehensively review the medical literature on neonatal nosocomial infections.
  • To emphasize neonatal colonization, immune factors, transmission, epidemiology, surveillance, prevention, and etiologic agents.

Main Methods:

  • Systematic electronic search of Medline and LILACS databases.
  • Inclusion of relevant articles published within the last ten years.

Main Results:

  • Prevalence rates of neonatal nosocomial infections range from 9.3% to 25.6%, with over 50% of neonates weighing less than 1500g affected, increasing mortality.
  • Common infections include skin/soft tissue lesions (gram-positive organisms), sepsis, and pneumonia (S. aureus, S. epidermidis, E. coli, K. pneumoniae, E. cloacae).
  • Increasing antimicrobial resistance is noted; tailored surveillance programs aid in outbreak identification and rational antibiotic use.

Conclusions:

  • Neonatal nosocomial infections pose a significant public health challenge.
  • Control necessitates integrated measures encompassing pregnant women, hospital environments, healthcare staff, and neonates.
  • While novel prophylactic strategies exist for preterm infants, they are costly and do not replace the need for continuous epidemiological surveillance and control.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: